Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (461-470 of 476) with videos related to

Pageof 48
Sort By:
Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic LeukemiaLuca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Leukemia|April 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?Maria Julia Montoro, Pamela Acha, Claudia Haferlach, et al.
Blood|June 14, 2021
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Manja Meggendorfer, Matteo Zampini, et al.
Leukemia|January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroupsDetlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Blood|November 1, 2021
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, et al.
Nature Genetics|March 31, 2019
Genomic subtyping and therapeutic targeting of acute erythroleukemiaIlaria Iacobucci, Ji Wen, Manja Meggendorfer, et al.
European Heart Journal|September 3, 2025
Clonal haematopoiesis of indeterminate potential and mortality in coronary artery diseaseMoritz von Scheidt, Shaunak S Adkar, Johannes Krefting, et al.
Blood Cancer Discovery|March 31, 2025
Enhancer hijacking discovery in acute myeloid leukemia by pyjacker identifies MNX1 activation via deletion 7qEtienne Sollier, Anna Riedel, Umut H Toprak, et al.
Cancer Discovery|June 9, 2021
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell LeukemiaLindsey E Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Pageof 48

Showing results (461-470 of 476) with videos related to

Sort By:
Pageof 48
Nature Communications|April 8, 2015
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasmsWilliam Tapper, Amy V Jones, Robert Kralovics, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic LeukemiaLuca Lanino, Anthony M Hunter, Nico Gagelmann, et al.
Leukemia|April 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?Maria Julia Montoro, Pamela Acha, Claudia Haferlach, et al.
Blood|June 14, 2021
Clinical relevance of clonal hematopoiesis in persons aged ≥80 yearsMarianna Rossi, Manja Meggendorfer, Matteo Zampini, et al.
Leukemia|January 13, 2019
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroupsDetlef Haase, Kristen E Stevenson, Donna Neuberg, et al.
Blood|November 1, 2021
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Sylvie D Freeman, Gert J Ossenkoppele, et al.
Nature Genetics|March 31, 2019
Genomic subtyping and therapeutic targeting of acute erythroleukemiaIlaria Iacobucci, Ji Wen, Manja Meggendorfer, et al.
European Heart Journal|September 3, 2025
Clonal haematopoiesis of indeterminate potential and mortality in coronary artery diseaseMoritz von Scheidt, Shaunak S Adkar, Johannes Krefting, et al.
Blood Cancer Discovery|March 31, 2025
Enhancer hijacking discovery in acute myeloid leukemia by pyjacker identifies MNX1 activation via deletion 7qEtienne Sollier, Anna Riedel, Umut H Toprak, et al.
Cancer Discovery|June 9, 2021
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell LeukemiaLindsey E Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Pageof 48